- Home
- OLMA vs WVVI Comparison
OLMA vs WVVI Comparison
Compare OLMA & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLMA
- WVVI
- Stock Information
- Founded
- OLMA 2006
- WVVI 1983
- Country
- OLMA United States
- WVVI United States
- Employees
- OLMA N/A
- WVVI N/A
- Industry
- OLMA Biotechnology: Pharmaceutical Preparations
- WVVI Beverages (Production/Distribution)
- Sector
- OLMA Health Care
- WVVI Consumer Staples
- Exchange
- OLMA Nasdaq
- WVVI Nasdaq
- Market Cap
- OLMA 465.4M
- WVVI 16.5M
- IPO Year
- OLMA 2020
- WVVI N/A
- Fundamental
- Price
- OLMA $6.10
- WVVI $3.33
- Analyst Decision
- OLMA Strong Buy
- WVVI
- Analyst Count
- OLMA 5
- WVVI 0
- Target Price
- OLMA $26.25
- WVVI N/A
- AVG Volume (30 Days)
- OLMA 1.2M
- WVVI 4.1K
- Earning Date
- OLMA 11-12-2024
- WVVI 11-12-2024
- Dividend Yield
- OLMA N/A
- WVVI N/A
- EPS Growth
- OLMA N/A
- WVVI N/A
- EPS
- OLMA N/A
- WVVI N/A
- Revenue
- OLMA N/A
- WVVI $39,259,016.00
- Revenue This Year
- OLMA N/A
- WVVI N/A
- Revenue Next Year
- OLMA N/A
- WVVI N/A
- P/E Ratio
- OLMA N/A
- WVVI N/A
- Revenue Growth
- OLMA N/A
- WVVI N/A
- 52 Week Low
- OLMA $5.56
- WVVI $3.17
- 52 Week High
- OLMA $16.78
- WVVI $5.40
- Technical
- Relative Strength Index (RSI)
- OLMA 27.05
- WVVI 51.22
- Support Level
- OLMA $5.56
- WVVI $3.17
- Resistance Level
- OLMA $6.87
- WVVI $3.34
- Average True Range (ATR)
- OLMA 0.81
- WVVI 0.07
- MACD
- OLMA -0.28
- WVVI 0.01
- Stochastic Oscillator
- OLMA 10.12
- WVVI 94.12
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.